What is the current annual EBIT of TMO?

As of today, TMO annual EBIT is $8.11B

What is 1-year change in TMO annual EBIT?

TMO annual EBIT is up +5.83% year-over-year

What is 3-year change in TMO annual EBIT?

TMO annual EBIT is down -4.88% over the past 3 years

How far is TMO annual EBIT from its all-time high?

TMO annual EBIT is currently -21.41% below its historical high of $10.32B set on December 31, 2021

How does TMO annual EBIT rank versus sector peers?

TMO annual EBIT is higher than 98.58% of companies in Healthcare sector

When is TMO next annual earnings release?

The next annual earnings release for TMO is on January 28, 2027

What is the current quarterly EBIT of TMO?

As of today, TMO quarterly EBIT is $2.46B

What is TMO quarterly EBIT most recent change?

TMO quarterly EBIT was up +8.65% on September 26, 2026

What is 1-year change in TMO quarterly EBIT?

TMO quarterly EBIT is up +14.30% year-over-year

How far is TMO quarterly EBIT from its all-time high?

TMO quarterly EBIT is currently -21.49% below its historical high of $3.14B set on December 31, 2020

How does TMO quarterly EBIT rank versus sector peers?

TMO quarterly EBIT is higher than 98.59% of companies in Healthcare sector

When is TMO next earnings release?

The next earnings release for TMO is on January 28, 2027

What is the current TTM EBIT of TMO?

As of today, TMO TTM EBIT is $9.15B

What is TMO TTM EBIT most recent change?

TMO TTM EBIT was up +3.48% on September 26, 2026

What is 1-year change in TMO TTM EBIT?

TMO TTM EBIT is up +11.49% year-over-year

How far is TMO TTM EBIT from its all-time high?

TMO TTM EBIT is currently -15.66% below its historical high of $10.85B set on June 1, 2021

How does TMO TTM EBIT rank versus sector peers?

TMO TTM EBIT is higher than 98.59% of companies in Healthcare sector

When is TMO next earnings release?

The next earnings release for TMO is on January 28, 2027

TMO EBIT History & Chart Since 1980

Annual EBIT

$8.11B$447.00M+5.83%

December 31, 2025

Summary

Current Value: As of today, TMO annual EBIT is $8.11B, up +5.83% on December 31, 2025
Historical Performance: TMO annual EBIT is down -4.88% over the past 3 years, up +2.68% over the past 5 years
All-Time High Comparison: TMO annual EBIT is currently -21.41% below its historical high of $10.32B set on December 31, 2021
3-Year Low Comparison: TMO annual EBIT is +8.90% above its 3-year low of $7.45B reached on December 31, 2023
Sector Comparison: TMO annual EBIT is higher than 98.58% of companies in Healthcare sector

EBIT Chart

beforeafter

Performance

TMO Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBIT	Dec 31, 25	$8.11B	+5.8%	-4.9%	+2.7%	+541.3%
Quarterly EBIT	Sep 26, 26	$2.46B	+14.3%	+24.7%	+4.9%	+561.5%
TTM EBIT	Sep 26, 26	$9.15B	+11.5%	+23.0%	-15.3%	+532.9%
Price	Oct 30, 26	$697.00	+22.8%	+55.7%	+9.6%	+1301.0%
PE Ratio	Oct 30, 26	36.77	+12.2%	+25.4%	+24.5%	+95.7%
Annual Revenue	Dec 31, 25	$44.56B	+3.9%	-0.8%	+38.3%	+328.7%
Annual EPS	Dec 31, 25	$17.74	+7.2%	+0.5%	+11.0%	+603.0%
Annual EBITDA	Dec 31, 25	$10.89B	+1.1%	-8.5%	+6.5%	+443.3%
Annual Net Income	Dec 31, 25	$6.72B	+6.0%	-3.5%	+5.4%	+581.6%

EBIT Highs

TMO Annual EBIT Highs Comparison
Period	High	Date	Current
3Y	$8.53B	N/A	-4.9%
5Y	$10.32B	Dec 31, 21	-21.4%
All	$10.32B	Dec 31, 21	-21.4%

EBIT Lows

TMO Annual EBIT Lows Comparison
Period	Low	Date	Current
3Y	$7.45B	Dec 31, 23	+8.9%
5Y	$7.45B	Dec 31, 23	+8.9%
All	$147.00K	Dec 1, 83	>+9999.0%

EBIT History

Year	Value	Change
2025	$8.11B	+5.8%
2024	$7.66B	+2.9%
2023	$7.45B	-12.7%
2022	$8.53B	-17.4%
2021	$10.32B	+30.7%
2020	$7.90B	+85.4%
2019	$4.26B	+10.0%
2018	$3.87B	+18.5%
2017	$3.27B	+14.3%
2016	$2.86B	+14.6%
2015	$2.49B	+6.2%
2014	$2.35B	+30.6%
2013	$1.80B	+10.4%
2012	$1.63B	+10.0%
2011	$1.48B	+17.2%
2010	$1.26B	+13.1%
2009	$1.12B	-11.7%
2008	$1.27B	+18.8%
2007	$1.07B	+191.8%
2006	$365.30M	+24.3%
2005	$293.77M	+15.5%
2004	$254.44M	+8.9%
2003	$233.55M	+7.8%

Year	Value	Change
2002	$216.73M	+12.3%
2001	$193.00M	-11.2%
2000	$217.45M	-12.5%
1999	$248.60M	-35.3%
1998	$384.32M	-5.6%
1997	$407.06M	+43.3%
1996	$284.11M	+14.8%
1995	$247.42M	+37.6%
1994	$179.78M	+45.4%
1993	$123.61M	+81.1%
1992	$68.26M	+62.7%
1991	$41.95M	+18.0%
1990	$35.56M	+78.8%
1989	$19.89M	-1.2%
1988	$20.14M	+55.4%
1987	$12.96M	+4.8%
1986	$12.37M	+9.1%
1985	$11.34M	+6.3%
1984	$10.67M	+7,159.9%
1983	$147.00K	-97.6%
1982	$6.22M	-60.5%
1981	$15.75M	+21.7%
1980	$12.94M	-

FAQ

What is the current annual EBIT of TMO?: As of today, TMO annual EBIT is $8.11B
What is 1-year change in TMO annual EBIT?: TMO annual EBIT is up +5.83% year-over-year
What is 3-year change in TMO annual EBIT?: TMO annual EBIT is down -4.88% over the past 3 years
How far is TMO annual EBIT from its all-time high?: TMO annual EBIT is currently -21.41% below its historical high of $10.32B set on December 31, 2021
How does TMO annual EBIT rank versus sector peers?: TMO annual EBIT is higher than 98.58% of companies in Healthcare sector
When is TMO next annual earnings release?: The next annual earnings release for TMO is on January 28, 2027

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Quarterly EBIT

$2.46B$196.00M+8.65%

September 26, 2026

Summary

Current Value: As of today, TMO quarterly EBIT is $2.46B, up +8.65% on September 26, 2026
Historical Performance: TMO quarterly EBIT is up +14.30% year-over-year, up +24.72% over the past 3 years
All-Time High Comparison: TMO quarterly EBIT is currently -21.49% below its historical high of $3.14B set on December 31, 2020
3-Year Low Comparison: TMO quarterly EBIT is +43.14% above its 3-year low of $1.72B reached on March 30, 2024
Sector Comparison: TMO quarterly EBIT is higher than 98.59% of companies in Healthcare sector

Performance

TMO Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBIT	Sep 26, 26	$2.46B	+8.7%	+14.3%	+24.7%	+4.9%
Annual EBIT	Dec 31, 25	$8.11B	–	+5.8%	-4.9%	+2.7%
TTM EBIT	Sep 26, 26	$9.15B	+3.5%	+11.5%	+23.0%	-15.3%
Price	Oct 30, 26	$697.00	+21.4%	+22.8%	+55.7%	+9.6%
PE Ratio	Oct 30, 26	36.77	+19.0%	+12.2%	+25.4%	+24.5%
Quarterly Revenue	Sep 26, 26	$12.14B	+1.2%	+9.1%	+14.8%	+30.1%
Quarterly EPS	Sep 26, 26	$4.64	-0.9%	+8.5%	+5.0%	-3.2%
Quarterly EBITDA	Sep 26, 26	$3.18B	+3.3%	+13.1%	+12.6%	+7.0%
Quarterly Net Income	Sep 26, 26	$1.73B	-0.9%	+6.5%	+1.9%	-9.2%

Quarterly EBIT Highs

TMO Quarterly EBIT Highs Comparison
Period	High	Date	Current
1Y	$2.46B	Sep 26, 26	at high
3Y	$2.46B	Sep 26, 26	at high
5Y	$2.84B	Mar 1, 22	-13.4%
All	$3.14B	Dec 31, 20	-21.5%

Quarterly EBIT Lows

TMO Quarterly EBIT Lows Comparison
Period	Low	Date	Current
1Y	$1.97B	Mar 28, 26	+24.9%
3Y	$1.72B	Mar 30, 24	+43.1%
5Y	$1.70B	Mar 1, 23	+44.5%
All	-$331.10M	Dec 31, 88	+843.6%

Quarterly EBIT History

Month	Value	Change
Sep 2026	$2.46B	+8.6%
Jun 2026	$2.27B	+15.0%
Mar 2026	$1.97B	-19.7%
Dec 2025	$2.45B	+13.9%
Sep 2025	$2.15B	+10.6%
Jun 2025	$1.95B	+5.9%
Mar 2025	$1.84B	-18.9%
Dec 2024	$2.27B	+19.1%
Sep 2024	$1.90B	+8.3%
Jun 2024	$1.76B	+2.2%
Mar 2024	$1.72B	-13.7%
Dec 2023	$1.99B	+1.0%
Sep 2023	$1.97B	+10.8%
Jun 2023	$1.78B	+4.5%
Mar 2023	$1.70B	-14.2%
Dec 2022	$1.99B	+13.0%
Sep 2022	$1.76B	-9.5%
Jun 2022	$1.94B	-31.7%
Mar 2022	$2.84B	+6.1%
Dec 2021	$2.68B	+14.1%
Sep 2021	$2.35B	+4.3%
Jun 2021	$2.25B	-26.8%
Mar 2021	$3.08B	-1.9%
Dec 2020	$3.14B	+31.2%
Sep 2020	$2.39B	+65.2%
Jun 2020	$1.45B	+52.5%
Mar 2020	$949.00M	-25.2%
Dec 2019	$1.27B	+28.4%
Sep 2019	$988.00M	-6.4%
Jun 2019	$1.06B	+11.6%
Mar 2019	$946.00M	-20.3%
Dec 2018	$1.19B	+34.7%
Sep 2018	$881.00M	-8.2%
Jun 2018	$960.00M	+13.7%
Mar 2018	$844.00M	-16.4%
Dec 2017	$1.01B	+31.2%
Sep 2017	$769.00M	-1.2%
Jun 2017	$778.00M	+9.6%
Mar 2017	$709.70M	-16.2%
Dec 2016	$847.10M	+22.0%
Sep 2016	$694.60M	-1.0%
Jun 2016	$701.30M	+14.0%
Mar 2016	$615.40M	-18.4%
Dec 2015	$753.90M	+24.1%
Sep 2015	$607.70M	-1.4%
Jun 2015	$616.40M	+20.0%
Mar 2015	$513.60M	-24.8%
Dec 2014	$682.90M	+25.1%
Sep 2014	$545.90M	-5.3%
Jun 2014	$576.60M	+6.0%
Mar 2014	$543.80M	+5.3%
Dec 2013	$516.60M	+21.0%
Sep 2013	$426.90M	-1.4%
Jun 2013	$433.10M	+2.6%
Mar 2013	$422.10M	-4.7%
Dec 2012	$443.10M	+14.1%
Sep 2012	$388.30M	-4.5%
Jun 2012	$406.70M	+4.5%
Mar 2012	$389.10M	-4.1%
Dec 2011	$405.80M	+9.0%
Sep 2011	$372.20M	+3.6%
Jun 2011	$359.10M	+4.8%
Mar 2011	$342.80M	-7.9%
Dec 2010	$372.10M	+12.1%
Sep 2010	$331.90M	+2.5%
Jun 2010	$323.70M	+2.2%
Mar 2010	$316.60M	-10.4%
Dec 2009	$353.40M	+22.2%
Sep 2009	$289.30M	+6.6%
Jun 2009	$271.50M	+33.3%
Mar 2009	$203.70M	-40.7%
Dec 2008	$343.70M	+13.9%
Sep 2008	$301.70M	-7.2%
Jun 2008	$325.00M	+9.8%
Mar 2008	$295.90M	-2.6%
Dec 2007	$303.90M	+15.5%
Sep 2007	$263.20M	+0.3%
Jun 2007	$262.50M	+11.1%
Mar 2007	$236.20M	+77.1%
Dec 2006	$133.37M	+62.1%
Sep 2006	$82.27M	+5.2%
Jun 2006	$78.22M	+9.5%
Mar 2006	$71.44M	-23.3%
Dec 2005	$93.13M	+25.3%
Sep 2005	$74.35M	+11.1%
Jun 2005	$66.90M	+12.6%

Month	Value	Change
Mar 2005	$59.41M	-18.5%
Dec 2004	$72.87M	+12.7%
Sep 2004	$64.66M	+8.1%
Jun 2004	$59.79M	-5.8%
Mar 2004	$63.46M	-16.8%
Dec 2003	$76.28M	+34.6%
Sep 2003	$56.65M	+6.6%
Jun 2003	$53.15M	+12.1%
Mar 2003	$47.40M	-28.1%
Dec 2002	$65.89M	+23.1%
Sep 2002	$53.50M	+5.6%
Jun 2002	$50.66M	+12.3%
Mar 2002	$45.12M	-14.8%
Dec 2001	$52.94M	+38.6%
Sep 2001	$38.21M	-25.3%
Jun 2001	$51.14M	+0.8%
Mar 2001	$50.72M	+15.7%
Dec 2000	$43.86M	-30.1%
Sep 2000	$62.70M	+8.9%
Jun 2000	$57.60M	+11.6%
Mar 2000	$51.62M	>+9,900.0%
Dec 1999	$0.00	-100.0%
Sep 1999	$93.35M	+12.8%
Jun 1999	$82.76M	+22.2%
Mar 1999	$67.75M	-13.6%
Dec 1998	$78.46M	-24.5%
Sep 1998	$103.87M	-5.2%
Jun 1998	$109.60M	+18.6%
Mar 1998	$92.40M	+8,499.7%
Dec 1997	-$1.10M	-100.9%
Sep 1997	$119.30M	+21.2%
Jun 1997	$98.40M	+42.8%
Mar 1997	$68.90M	-21.1%
Dec 1996	$87.30M	+11.8%
Sep 1996	$78.10M	+25.8%
Jun 1996	$62.10M	+9.1%
Mar 1996	$56.90M	-23.0%
Dec 1995	$73.90M	+8.0%
Sep 1995	$68.40M	+18.5%
Jun 1995	$57.70M	+21.7%
Mar 1995	$47.40M	-11.2%
Dec 1994	$53.40M	+13.9%
Sep 1994	$46.90M	+9.6%
Jun 1994	$42.80M	+16.0%
Mar 1994	$36.90M	-2.9%
Dec 1993	$38.00M	-4.0%
Sep 1993	$39.60M	+68.5%
Jun 1993	$23.50M	0.0%
Mar 1993	$23.50M	+26.3%
Dec 1992	$18.60M	-22.5%
Sep 1992	$24.00M	+41.2%
Jun 1992	$17.00M	+95.4%
Mar 1992	$8.70M	-4.4%
Dec 1991	$9.10M	0.0%
Sep 1991	$9.10M	-2.2%
Jun 1991	$9.30M	+1.1%
Mar 1991	$9.20M	-33.8%
Dec 1990	$13.90M	+3.0%
Sep 1990	$13.50M	+743.8%
Jun 1990	$1.60M	-72.4%
Mar 1990	$5.80M	+56.8%
Dec 1989	$3.70M	+19.4%
Sep 1989	$3.10M	-97.9%
Jun 1989	$150.80M	+9.9%
Mar 1989	$137.20M	+141.4%
Dec 1988	-$331.10M	-363.6%
Sep 1988	$125.60M	+3.5%
Jun 1988	$121.40M	+17.6%
Mar 1988	$103.20M	+134.7%
Dec 1987	-$297.50M	-372.7%
Sep 1987	$109.10M	+14.2%
Jun 1987	$95.50M	+2.5%
Mar 1987	$93.20M	+140.4%
Dec 1986	-$230.80M	-370.9%
Sep 1986	$85.20M	+6.9%
Jun 1986	$79.70M	+1.8%
Mar 1986	$78.30M	+140.9%
Dec 1985	-$191.40M	-403.3%
Sep 1985	$63.10M	0.0%
Jun 1985	$63.10M	-9.9%
Mar 1985	$70.00M	+143.8%
Dec 1984	-$159.80M	-362.8%
Sep 1984	$60.80M	+7.2%
Jun 1984	$56.70M	+7.4%
Mar 1984	$52.80M	-

FAQ

What is the current quarterly EBIT of TMO?: As of today, TMO quarterly EBIT is $2.46B
What is TMO quarterly EBIT most recent change?: TMO quarterly EBIT was up +8.65% on September 26, 2026
What is 1-year change in TMO quarterly EBIT?: TMO quarterly EBIT is up +14.30% year-over-year
How far is TMO quarterly EBIT from its all-time high?: TMO quarterly EBIT is currently -21.49% below its historical high of $3.14B set on December 31, 2020
How does TMO quarterly EBIT rank versus sector peers?: TMO quarterly EBIT is higher than 98.59% of companies in Healthcare sector
When is TMO next earnings release?: The next earnings release for TMO is on January 28, 2027

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

TTM EBIT

$9.15B$308.00M+3.48%

September 26, 2026

Summary

Current Value: As of today, TMO TTM EBIT is $9.15B, up +3.48% on September 26, 2026
Historical Performance: TMO TTM EBIT is up +11.49% year-over-year, up +22.96% over the past 3 years
All-Time High Comparison: TMO TTM EBIT is currently -15.66% below its historical high of $10.85B set on June 1, 2021
3-Year Low Comparison: TMO TTM EBIT is +24.11% above its 3-year low of $7.38B reached on September 28, 2024
Sector Comparison: TMO TTM EBIT is higher than 98.59% of companies in Healthcare sector

Performance

TMO Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBIT	Sep 26, 26	$9.15B	+3.5%	+11.5%	+23.0%	-15.3%
Annual EBIT	Dec 31, 25	$8.11B	–	+5.8%	-4.9%	+2.7%
Quarterly EBIT	Sep 26, 26	$2.46B	+8.7%	+14.3%	+24.7%	+4.9%
Price	Oct 30, 26	$697.00	+21.4%	+22.8%	+55.7%	+9.6%
PE Ratio	Oct 30, 26	36.77	+19.0%	+12.2%	+25.4%	+24.5%
TTM Revenue	Sep 26, 26	$47.35B	+2.2%	+8.3%	+9.1%	+21.2%
TTM EPS	Sep 26, 26	$18.95	+2.0%	+9.5%	+24.2%	-12.0%
TTM EBITDA	Sep 26, 26	$12.16B	+3.1%	+10.5%	+11.9%	-8.8%
TTM Net Income	Sep 26, 26	$7.10B	+1.5%	+7.9%	+19.8%	-17.2%

TTM EBIT Highs

TMO TTM EBIT Highs Comparison
Period	High	Date	Current
1Y	$9.15B	Sep 26, 26	at high
3Y	$9.15B	Sep 26, 26	at high
5Y	$10.81B	N/A	-15.3%
All	$10.85B	Jun 1, 21	-15.7%

TTM EBIT Lows

TMO TTM EBIT Lows Comparison
Period	Low	Date	Current
1Y	$8.21B	N/A	+11.5%
3Y	$7.38B	Sep 28, 24	+24.1%
5Y	$7.23B	Jun 1, 23	+26.6%
All	-$40.00M	Sep 30, 89	>+9999.0%

TTM EBIT History

Month	Value	Change
Sep 2026	$9.15B	+3.5%
Jun 2026	$8.85B	+3.7%
Mar 2026	$8.53B	+1.6%
Dec 2025	$8.40B	+2.3%
Sep 2025	$8.21B	+3.1%
Jun 2025	$7.96B	+2.4%
Mar 2025	$7.77B	+1.6%
Dec 2024	$7.65B	+3.7%
Sep 2024	$7.38B	-0.9%
Jun 2024	$7.45B	-0.3%
Mar 2024	$7.47B	+0.2%
Dec 2023	$7.45B	+0.1%
Sep 2023	$7.44B	+3.0%
Jun 2023	$7.23B	-2.2%
Mar 2023	$7.39B	-13.3%
Dec 2022	$8.53B	-7.5%
Sep 2022	$9.22B	-6.0%
Jun 2022	$9.81B	-3.1%
Mar 2022	$10.12B	-2.3%
Dec 2021	$10.35B	-4.2%
Sep 2021	$10.81B	-0.4%
Jun 2021	$10.85B	+8.0%
Mar 2021	$10.05B	+26.8%
Dec 2020	$7.92B	+30.8%
Sep 2020	$6.06B	+30.2%
Jun 2020	$4.65B	+9.2%
Mar 2020	$4.26B	+0.1%
Dec 2019	$4.26B	+2.0%
Sep 2019	$4.18B	+2.6%
Jun 2019	$4.07B	+2.4%
Mar 2019	$3.97B	+2.6%
Dec 2018	$3.87B	+4.8%
Sep 2018	$3.69B	+3.1%
Jun 2018	$3.58B	+5.4%
Mar 2018	$3.40B	+4.1%
Dec 2017	$3.27B	+5.2%
Sep 2017	$3.10B	+2.5%
Jun 2017	$3.03B	+2.6%
Mar 2017	$2.95B	+3.3%
Dec 2016	$2.86B	+3.4%
Sep 2016	$2.77B	+3.2%
Jun 2016	$2.68B	+3.3%
Mar 2016	$2.59B	+4.1%
Dec 2015	$2.49B	+2.9%
Sep 2015	$2.42B	+2.6%
Jun 2015	$2.36B	+1.7%
Mar 2015	$2.32B	-1.3%
Dec 2014	$2.35B	+7.6%
Sep 2014	$2.18B	+5.8%
Jun 2014	$2.06B	+7.5%
Mar 2014	$1.92B	+6.8%
Dec 2013	$1.80B	+4.3%
Sep 2013	$1.73B	+2.3%
Jun 2013	$1.69B	+1.6%
Mar 2013	$1.66B	+2.0%
Dec 2012	$1.63B	+2.3%
Sep 2012	$1.59B	+1.0%
Jun 2012	$1.57B	+3.1%
Mar 2012	$1.53B	+3.1%
Dec 2011	$1.48B	+2.3%
Sep 2011	$1.45B	+2.9%
Jun 2011	$1.41B	+2.6%
Mar 2011	$1.37B	+1.9%
Dec 2010	$1.34B	+1.4%
Sep 2010	$1.33B	+3.3%
Jun 2010	$1.28B	+4.2%
Mar 2010	$1.23B	+10.1%
Dec 2009	$1.12B	+0.9%
Sep 2009	$1.11B	-1.1%
Jun 2009	$1.12B	-4.6%
Mar 2009	$1.17B	-7.3%
Dec 2008	$1.27B	+3.2%
Sep 2008	$1.23B	+3.2%
Jun 2008	$1.19B	+5.6%
Mar 2008	$1.13B	+5.6%
Dec 2007	$1.07B	+19.0%
Sep 2007	$895.27M	+25.3%
Jun 2007	$714.34M	+34.8%
Mar 2007	$530.06M	+45.1%
Dec 2006	$365.30M	+12.4%
Sep 2006	$325.06M	+2.5%
Jun 2006	$317.13M	+3.7%
Mar 2006	$305.81M	+4.1%
Dec 2005	$293.77M	+7.4%
Sep 2005	$273.52M	+3.7%
Jun 2005	$263.82M	+2.8%

Month	Value	Change
Mar 2005	$256.71M	-1.6%
Dec 2004	$260.77M	-1.3%
Sep 2004	$264.18M	+3.1%
Jun 2004	$256.18M	+2.7%
Mar 2004	$249.54M	+6.9%
Dec 2003	$233.48M	+4.7%
Sep 2003	$223.10M	+1.4%
Jun 2003	$219.95M	+1.1%
Mar 2003	$217.46M	+1.1%
Dec 2002	$215.17M	+6.4%
Sep 2002	$202.22M	+8.2%
Jun 2002	$186.92M	-0.3%
Mar 2002	$187.39M	-2.9%
Dec 2001	$193.00M	+4.9%
Sep 2001	$183.92M	-11.8%
Jun 2001	$208.42M	-3.0%
Mar 2001	$214.88M	-0.4%
Dec 2000	$215.78M	+25.5%
Sep 2000	$171.92M	-15.1%
Jun 2000	$202.56M	-11.1%
Mar 2000	$227.73M	-6.6%
Dec 1999	$243.86M	-24.3%
Sep 1999	$322.32M	-3.2%
Jun 1999	$332.84M	-7.5%
Mar 1999	$359.67M	-6.4%
Dec 1998	$384.32M	+26.1%
Sep 1998	$304.77M	-4.8%
Jun 1998	$320.19M	+3.6%
Mar 1998	$309.00M	+8.2%
Dec 1997	$285.50M	-23.6%
Sep 1997	$373.90M	+12.4%
Jun 1997	$332.70M	+12.2%
Mar 1997	$296.40M	+4.2%
Dec 1996	$284.40M	+4.9%
Sep 1996	$271.00M	+3.7%
Jun 1996	$261.30M	+1.7%
Mar 1996	$256.90M	+3.8%
Dec 1995	$247.40M	+9.0%
Sep 1995	$226.90M	+10.5%
Jun 1995	$205.40M	+7.8%
Mar 1995	$190.50M	+5.8%
Dec 1994	$180.00M	+9.4%
Sep 1994	$164.60M	+4.6%
Jun 1994	$157.30M	+14.0%
Mar 1994	$138.00M	+10.8%
Dec 1993	$124.60M	+18.4%
Sep 1993	$105.20M	+17.4%
Jun 1993	$89.60M	+7.8%
Mar 1993	$83.10M	+21.7%
Dec 1992	$68.30M	+16.2%
Sep 1992	$58.80M	+33.9%
Jun 1992	$43.90M	+21.3%
Mar 1992	$36.20M	-1.4%
Dec 1991	$36.70M	-11.6%
Sep 1991	$41.50M	-9.6%
Jun 1991	$45.90M	+20.2%
Mar 1991	$38.20M	+9.8%
Dec 1990	$34.80M	+41.5%
Sep 1990	$24.60M	+73.2%
Jun 1990	$14.20M	-91.3%
Mar 1990	$163.40M	-44.6%
Dec 1989	$294.80M	+837.0%
Sep 1989	-$40.00M	-148.5%
Jun 1989	$82.50M	+55.4%
Mar 1989	$53.10M	+178.0%
Dec 1988	$19.10M	-63.8%
Sep 1988	$52.70M	+45.6%
Jun 1988	$36.20M	+251.5%
Mar 1988	$10.30M	+3,333.3%
Dec 1987	$300.00K	-99.6%
Sep 1987	$67.00M	+55.5%
Jun 1987	$43.10M	+57.9%
Mar 1987	$27.30M	+120.2%
Dec 1986	$12.40M	-76.1%
Sep 1986	$51.80M	+74.4%
Jun 1986	$29.70M	+126.7%
Mar 1986	$13.10M	+172.9%
Dec 1985	$4.80M	-86.8%
Sep 1985	$36.40M	+6.7%
Jun 1985	$34.10M	+23.1%
Mar 1985	$27.70M	+163.8%
Dec 1984	$10.50M	-93.8%
Sep 1984	$170.30M	+55.5%
Jun 1984	$109.50M	+107.4%
Mar 1984	$52.80M	-

FAQ

What is the current TTM EBIT of TMO?: As of today, TMO TTM EBIT is $9.15B
What is TMO TTM EBIT most recent change?: TMO TTM EBIT was up +3.48% on September 26, 2026
What is 1-year change in TMO TTM EBIT?: TMO TTM EBIT is up +11.49% year-over-year
How far is TMO TTM EBIT from its all-time high?: TMO TTM EBIT is currently -15.66% below its historical high of $10.85B set on June 1, 2021
How does TMO TTM EBIT rank versus sector peers?: TMO TTM EBIT is higher than 98.59% of companies in Healthcare sector
When is TMO next earnings release?: The next earnings release for TMO is on January 28, 2027

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Data Sources & References

TMO Official Website www.thermofisher.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo